Последние добавленные видео:
T315I
-
13 years ago
13602 13 years ago 3:09LG T315i
-
2 years ago
481 2 years ago 1:54Targeting the T315I mutation with ponatinib to treat patients with R/R Ph+ ALL
-
1 year ago
94 1 year ago 1:57Post-hoc analysis of OPTIC: patient responses to ponatinib by T315I mutational status
-
1 year ago
61 1 year ago 1:32Post hoc analysis of OPTIC: patient responses by T315I mutation status
-
5 years ago
1650 5 years ago 17:31Debate: Chronic-Phase CML Patient Develops a T315I Mutation - Experimental Therapy
-
5 years ago
224 5 years ago 5:31Case 2: Additional Treatment Considerations for T315I-Mutated CML
-
2 years ago
535 2 years ago 1:03Phase I study of asciminib in patients with CP-CML carrying the T315I mutation
-
10 months ago
65 10 months ago 2:32Dr Deininger on Long-Term Outcomes With Ponatinib in T315I-Mutant CP-CML
-
5 years ago
266 5 years ago 4:39Case 2: Relapsed CML With T315I Mutation
-
10 years ago
156 10 years ago 4:18Ponatinib Efficacy and Safety With the T315I Mutation: Long-Term Follow-up of Phase 1&2 Trials
-
2 months ago
10 2 months ago 10:27Expert Cancer Panel: CML chronic phase T315I mutated s/p multiple lines of therapy
-
5 years ago
437 5 years ago 5:07Case 2: Ponatinib for T315I-Mutated CML
-
5 years ago
1118 5 years ago 17:38Debate: Chronic-Phase CML Patient Develops a T315I Mutation - Transplant
-
12 years ago
497 12 years ago 1:10T315i
-
2 years ago
84 2 years ago 9:33CHRONIC MYELOID LEUKEMIA: RESISTANT / INTOLERANT AND T315I MUTANT: PART 1 @iam_haematology_oncology
-
4 years ago
275 4 years ago 1:11обзор LG-T315I
-
6 years ago
99193 6 years ago 4:20Tyrosine Kinase Inhibitors (TKIs) - Imatinib (Gleevec) - Pharmacology - CML and ALL
-
8 years ago
132 8 years ago 4:15What are the sensitivities of different CML therapies to various mutations including T315I?